Publications by authors named "Divya Avula"
Article Synopsis
- Recent studies have indicated that mitral valve replacement (MVR) may perform better hemodynamically compared to mitral valve repair (MVr) for ischemic mitral regurgitation, but with no significant survival difference at 2 years.
- A study analyzed outcomes of 111 patients who underwent either MVr or MVR, finding that although MVR experienced less regurgitation at 1 year, mortality rates between the two groups were similar after 1 and 2 years.
- The results suggest that MVr may be a viable surgical option for ischemic mitral regurgitation, offering comparable early mortality and mid-term valve performance to MVR.
Patients with left ventricular assist devices currently require long-term anticoagulation with warfarin. Warfarin requires frequent blood tests and is associated with adverse events when not in the therapeutic range. Apixaban is a possible alternative that is potentially better for compliance and requires no additional testing.
View Article and Find Full Text PDFBackground: Stentless porcine bioprothesis is a surgical strategy to treat aortic root disease. Use has been limited due to the concern for long-term valve degeneration. This study evaluated the perioperative and late outcomes of patients with aortic root disease requiring root replacement.
View Article and Find Full Text PDF